Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023

Upgrades

William Blair upgraded the previous rating for Under Armour Inc UAA from Hold to Buy. For the third quarter, Under Armour had an EPS of $0.16, compared to year-ago quarter EPS of $0.16. At the moment, the stock has a 52-week-high of $18.17 and a 52-week-low of $6.39. Under Armour closed at $8.07 at the end of the last trading period.

According to DA Davidson, the prior rating for Alamo Group Inc ALG was changed from Neutral to Buy. In the fourth quarter, Alamo Group showed an EPS of $2.44, compared to $1.62 from the year-ago quarter. The current stock performance of Alamo Group shows a 52-week-high of $186.37 and a 52-week-low of $109.39. Moreover, at the end of the last trading period, the closing price was at $169.69.

Wedbush upgraded the previous rating for On Holding AG ONON from Neutral to Outperform. For the third quarter, On Holding had an EPS of $0.07, compared to year-ago quarter EPS of $0.07. At the moment, the stock has a 52-week-high of $29.15 and a 52-week-low of $15.44. On Holding closed at $20.55 at the end of the last trading period.

Guggenheim upgraded the previous rating for TPI Composites Inc TPIC from Neutral to Buy. TPI Composites earned $1.38 in the fourth quarter, compared to $2.39 in the year-ago quarter. The current stock performance of TPI Composites shows a 52-week-high of $25.04 and a 52-week-low of $8.48. Moreover, at the end of the last trading period, the closing price was at $12.32.

Mizuho upgraded the previous rating for Block Inc SQ from Neutral to Buy. Block earned $0.22 in the fourth quarter, compared to $0.27 in the year-ago quarter. At the moment, the stock has a 52-week-high of $148.99 and a 52-week-low of $51.34. Block closed at $74.07 at the end of the last trading period.

For Skyworks Solutions Inc SWKS, Susquehanna upgraded the previous rating of Neutral to Positive. For the first quarter, Skyworks Solutions had an EPS of $2.59, compared to year-ago quarter EPS of $3.14. The stock has a 52-week-high of $141.22 and a 52-week-low of $76.17. At the end of the last trading period, Skyworks Solutions closed at $111.70.

Susquehanna upgraded the previous rating for Qualcomm Inc QCOM from Neutral to Positive. Qualcomm earned $2.37 in the first quarter, compared to $3.23 in the year-ago quarter. At the moment, the stock has a 52-week-high of $161.25 and a 52-week-low of $101.95. Qualcomm closed at $115.49 at the end of the last trading period.

According to Susquehanna, the prior rating for Intel Corp INTC was changed from Negative to Neutral. Intel earned $0.10 in the fourth quarter, compared to $1.09 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.51 and a 52-week-low of $24.59. Intel closed at $28.41 at the end of the last trading period.

For Motorola Solutions Inc MSI, JP Morgan upgraded the previous rating of Neutral to Buy. In the fourth quarter, Motorola Solns showed an EPS of $3.60, compared to $2.85 from the year-ago quarter. At the moment, the stock has a 52-week-high of $275.15 and a 52-week-low of $195.32. Motorola Solns closed at $258.72 at the end of the last trading period.

B of A Securities upgraded the previous rating for Takeda Pharmaceutical Co Ltd TAK from Neutral to Buy. The stock has a 52-week-high of $16.30 and a 52-week-low of $12.28. At the end of the last trading period, Takeda Pharmaceutical closed at $16.08.

Wells Fargo upgraded the previous rating for Progressive Corp PGR from Underweight to Overweight. For the fourth quarter, Progressive had an EPS of $1.50, compared to year-ago quarter EPS of $1.05. The current stock performance of Progressive shows a 52-week-high of $146.50 and a 52-week-low of $104.06. Moreover, at the end of the last trading period, the closing price was at $135.06.

For Choice Hotels International Inc CHH, Baird upgraded the previous rating of Neutral to Outperform. Choice Hotels Intl earned $1.26 in the fourth quarter, compared to $0.99 in the year-ago quarter. The stock has a 52-week-high of $150.15 and a 52-week-low of $104.20. At the end of the last trading period, Choice Hotels Intl closed at $112.15.

For HF Sinclair Corp DINO, Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. For the fourth quarter, HF Sinclair had an EPS of $2.97, compared to year-ago quarter EPS of $0.11. The stock has a 52-week-high of $66.17 and a 52-week-low of $34.25. At the end of the last trading period, HF Sinclair closed at $45.12.

For Mersana Therapeutics Inc MRSN, JP Morgan upgraded the previous rating of Neutral to Overweight. In the fourth quarter, Mersana Therapeutics showed an EPS of $0.44, compared to $0.68 from the year-ago quarter. At the moment, the stock has a 52-week-high of $8.32 and a 52-week-low of $2.69. Mersana Therapeutics closed at $4.55 at the end of the last trading period.

According to Telsey Advisory Group, the prior rating for Foot Locker Inc FL was changed from Market Perform to Outperform. For the third quarter, Foot Locker had an EPS of $1.27, compared to year-ago quarter EPS of $1.93. The stock has a 52-week-high of $47.22 and a 52-week-low of $23.86. At the end of the last trading period, Foot Locker closed at $41.04.

Oppenheimer upgraded the previous rating for ORIC Pharmaceuticals Inc ORIC from Perform to Outperform. ORIC Pharmaceuticals earned $0.50 in the third quarter, compared to $0.47 in the year-ago quarter. The current stock performance of ORIC Pharmaceuticals shows a 52-week-high of $7.45 and a 52-week-low of $2.37. Moreover, at the end of the last trading period, the closing price was at $4.33.

According to Stifel, the prior rating for FedEx Corp FDX was changed from Hold to Buy. The stock has a 52-week-high of $248.65 and a 52-week-low of $141.92. At the end of the last trading period, FedEx closed at $195.30.

According to Wolfe Research, the prior rating for Jones Lang LaSalle Inc JLL was changed from Peer Perform to Outperform. Jones Lang LaSalle earned $4.36 in the fourth quarter, compared to $8.66 in the year-ago quarter. The current stock performance of Jones Lang LaSalle shows a 52-week-high of $249.09 and a 52-week-low of $135.37. Moreover, at the end of the last trading period, the closing price was at $146.10.

See all analyst ratings upgrades.

Downgrades

For Halozyme Therapeutics Inc HALO, SVB Leerink downgraded the previous rating of Outperform to Market Perform. In the fourth quarter, Halozyme Therapeutics showed an EPS of $0.48, compared to $0.42 from the year-ago quarter. At the moment, the stock has a 52-week-high of $59.45 and a 52-week-low of $34.56. Halozyme Therapeutics closed at $40.05 at the end of the last trading period.

Craig-Hallum downgraded the previous rating for LivePerson Inc LPSN from Buy to Hold. For the fourth quarter, LivePerson had an EPS of $0.25, compared to year-ago quarter EPS of $0.62. At the moment, the stock has a 52-week-high of $26.64 and a 52-week-low of $7.96. LivePerson closed at $9.77 at the end of the last trading period.

DA Davidson downgraded the previous rating for AEye Inc LIDR from Buy to Neutral. For the fourth quarter, AEye had an EPS of $0.11, compared to year-ago quarter EPS of $0.13. The stock has a 52-week-high of $6.33 and a 52-week-low of $0.42. At the end of the last trading period, AEye closed at $0.43.

According to Maxim Group, the prior rating for Manhattan Bridge Capital Inc LOAN was changed from Buy to Hold. Manhattan Bridge Capital earned $0.10 in the fourth quarter, compared to $0.10 in the year-ago quarter. The current stock performance of Manhattan Bridge Capital shows a 52-week-high of $6.48 and a 52-week-low of $5.08. Moreover, at the end of the last trading period, the closing price was at $5.41.

According to Roth MKM, the prior rating for LivePerson Inc LPSN was changed from Buy to Neutral. LivePerson earned $0.25 in the fourth quarter, compared to $0.62 in the year-ago quarter. The current stock performance of LivePerson shows a 52-week-high of $26.64 and a 52-week-low of $7.96. Moreover, at the end of the last trading period, the closing price was at $9.77.

William Blair downgraded the previous rating for Kezar Life Sciences Inc KZR from Outperform to Market Perform. For the fourth quarter, Kezar Life Sciences had an EPS of $0.25, compared to year-ago quarter EPS of $0.25. The current stock performance of Kezar Life Sciences shows a 52-week-high of $18.50 and a 52-week-low of $4.30. Moreover, at the end of the last trading period, the closing price was at $4.61.

B of A Securities downgraded the previous rating for Medical Properties Trust Inc MPW from Buy to Neutral. In the fourth quarter, Medical Properties Trust showed an EPS of $0.43, compared to $0.47 from the year-ago quarter. The stock has a 52-week-high of $21.62 and a 52-week-low of $7.86. At the end of the last trading period, Medical Properties Trust closed at $8.15.

For Esperion Therapeutics Inc ESPR, B of A Securities downgraded the previous rating of Neutral to Underperform. For the fourth quarter, Esperion Therapeutics had an EPS of $0.76, compared to year-ago quarter EPS of $1.77. The current stock performance of Esperion Therapeutics shows a 52-week-high of $8.85 and a 52-week-low of $3.87. Moreover, at the end of the last trading period, the closing price was at $3.98.

TD Cowen downgraded the previous rating for Olaplex Holdings Inc OLPX from Outperform to Market Perform. Olaplex Hldgs earned $0.07 in the fourth quarter, compared to $0.10 in the year-ago quarter. The stock has a 52-week-high of $18.23 and a 52-week-low of $3.77. At the end of the last trading period, Olaplex Hldgs closed at $4.01.

For MYT Netherlands Parent BV MYTE, TD Cowen downgraded the previous rating of Outperform to Market Perform. MYT Netherlands Parent earned $0.13 in the second quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $15.85 and a 52-week-low of $5.93. At the end of the last trading period, MYT Netherlands Parent closed at $6.33.

BTIG downgraded the previous rating for Babylon Holdings Ltd BBLN from Buy to Neutral. For the fourth quarter, Babylon Holdings had an EPS of $4.50, compared to year-ago quarter EPS of $16.25. The stock has a 52-week-high of $120.50 and a 52-week-low of $6.33. At the end of the last trading period, Babylon Holdings closed at $6.86.

See all analyst ratings downgrades.

Initiations

For Safehold Inc SAFE, Exane BNP Paribas initiated coverage, by setting the current rating at Outperform. For the fourth quarter, Safehold had an EPS of $0.40, compared to year-ago quarter EPS of $0.38. The current stock performance of Safehold shows a 52-week-high of $59.33 and a 52-week-low of $23.68. Moreover, at the end of the last trading period, the closing price was at $29.09.

Exane BNP Paribas initiated coverage on Global Net Lease Inc GNL with an Underperform rating. The price target for Global Net Lease is set to $13.00. For the fourth quarter, Global Net Lease had an EPS of $0.24, compared to year-ago quarter EPS of $0.42. At the moment, the stock has a 52-week-high of $16.00 and a 52-week-low of $9.82. Global Net Lease closed at $13.03 at the end of the last trading period.

Ladenburg Thalmann initiated coverage on eMagin Corp EMAN with a Buy rating. The price target for eMagin is set to $3.00. eMagin earned $0.01 in the fourth quarter, compared to $0.03 in the year-ago quarter. The current stock performance of eMagin shows a 52-week-high of $1.46 and a 52-week-low of $0.59. Moreover, at the end of the last trading period, the closing price was at $1.32.

With a Buy rating, Redburn Partners initiated coverage on Under Armour Inc UAA. The price target seems to have been set at $13.50 for Under Armour. In the third quarter, Under Armour showed an EPS of $0.16, compared to $0.16 from the year-ago quarter. The stock has a 52-week-high of $18.17 and a 52-week-low of $6.39. At the end of the last trading period, Under Armour closed at $8.07.

With a Sell rating, Redburn Partners initiated coverage on Lululemon Athletica Inc LULU. The price target seems to have been set at $257.00 for Lululemon Athletica. In the third quarter, Lululemon Athletica showed an EPS of $2.00, compared to $1.62 from the year-ago quarter. The stock has a 52-week-high of $410.70 and a 52-week-low of $252.01. At the end of the last trading period, Lululemon Athletica closed at $293.23.

With a Sell rating, Redburn Partners initiated coverage on Nike Inc NKE. The price target seems to have been set at $100.00 for Nike. In the second quarter, Nike showed an EPS of $0.85, compared to $0.83 from the year-ago quarter. The stock has a 52-week-high of $139.86 and a 52-week-low of $82.24. At the end of the last trading period, Nike closed at $118.17.

With a Buy rating, Needham initiated coverage on Recursion Pharmaceuticals Inc RXRX. The price target seems to have been set at $17.00 for Recursion Pharmaceuticals. In the fourth quarter, Recursion Pharmaceuticals showed an EPS of $0.31, compared to $0.38 from the year-ago quarter. At the moment, the stock has a 52-week-high of $14.18 and a 52-week-low of $4.92. Recursion Pharmaceuticals closed at $7.48 at the end of the last trading period.

Goldman Sachs initiated coverage on Enhabit Inc EHAB with a Neutral rating. The price target for Enhabit is set to $15.00. In the fourth quarter, Enhabit showed an EPS of $0.32, compared to $0.59 from the year-ago quarter. At the moment, the stock has a 52-week-high of $23.51 and a 52-week-low of $11.66. Enhabit closed at $14.25 at the end of the last trading period.

With a Neutral rating, Piper Sandler initiated coverage on Samsara Inc IOT. The price target seems to have been set at $21.00 for Samsara. In the fourth quarter, Samsara showed an EPS of $0.02, compared to $0.05 from the year-ago quarter. The stock has a 52-week-high of $21.49 and a 52-week-low of $8.43. At the end of the last trading period, Samsara closed at $19.75.

With an Outperform rating, Raymond James initiated coverage on Organon & Co OGN. The price target seems to have been set at $33.00 for Organon. Organon earned $0.81 in the fourth quarter, compared to $1.13 in the year-ago quarter. At the moment, the stock has a 52-week-high of $39.09 and a 52-week-low of $21.11. Organon closed at $21.52 at the end of the last trading period.

UBS initiated coverage on Intuit Inc INTU with a Neutral rating. The price target for Intuit is set to $430.00. Intuit earned $2.20 in the second quarter, compared to $1.55 in the year-ago quarter. At the moment, the stock has a 52-week-high of $507.61 and a 52-week-low of $339.36. Intuit closed at $406.32 at the end of the last trading period.

With a Buy rating, Stifel initiated coverage on Theseus Pharmaceuticals Inc THRX. The price target seems to have been set at $24.00 for Theseus Pharmaceuticals. Theseus Pharmaceuticals earned $0.35 in the fourth quarter, compared to $0.24 in the year-ago quarter. The current stock performance of Theseus Pharmaceuticals shows a 52-week-high of $14.98 and a 52-week-low of $4.50. Moreover, at the end of the last trading period, the closing price was at $7.35.

See all analyst ratings initiations.